Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Galapagos, Roche Expand Alliance into Fibrosis | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Galapagos, Roche Expand Alliance into Fibrosis

Galapagos has achieved a $4.7 million milestone in its strategic alliance with Roche.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Galapagos has achieved a $4.7 million milestone in its strategic alliance with Roche. The alliance was also broadened to include novel target and drug discovery in fibrosis.

In January 2010, Galapagos entered its COPD strategic alliance with Roche, which was expanded from small molecule and antibody approaches to include peptides. This expansion covers fibrosis, which is the formation of scar tissue as a result of injury or long-term inflammation in the lungs or other organs.

“Through the alliance with Roche we have yet again proven our ability in novel target discovery across a wide range of disease areas working with human primary cells,” said Graham Dixon, senior vice president of Drug Discovery at Galapagos.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics